NASDAQ

Liminatus Pharma, Inc. - Class A (LIMN)

♥ 360 Thanks from members

Live price chart, market sentiment, and community perspectives for Liminatus Pharma, Inc. - Class A (NASDAQ: LIMN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Liminatus ManagementLeadership: CEOLeadership: CFOHolder: Institutional InvestorsCellular Immunotherapy PipelinesCancer Treatments#LIMN#Liminatus Pharma#Biotech#Cancer Immunotherapy#Clinical Trial